VPTDF - VentriPoint Diagnostics Ltd.

Other OTC - Other OTC Delayed Price. Currency in USD

VentriPoint Diagnostics Ltd.

2 Sheppard Avenue East
Suite 605
Toronto, ON M2N 5Y7

IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. George AdamsCEO & Director186.37kN/A1951
Mr. Desmond HirsonPresN/AN/AN/A
Ms. Ellen BriantCFO & Corp. Sec.81.19kN/AN/A
Dr. Alvira Macanovic Ph.D.VP of Devel. & OperationsN/AN/AN/A
Mr. Jim GrabaApplication Specialist & Chief TrainerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the Unites States, and China. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides a suite of applications for various heart diseases and imaging modalities, including congenital heart diseases, left or right heart failure, and normal hearts. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

Corporate Governance

VentriPoint Diagnostics Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.